O. Jin

528 total citations
11 papers, 328 citations indexed

About

O. Jin is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, O. Jin has authored 11 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in O. Jin's work include Hepatitis B Virus Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hepatitis C virus research (3 papers). O. Jin is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hepatitis C virus research (3 papers). O. Jin collaborates with scholars based in China, Canada and Australia. O. Jin's co-authors include Jagdish Butany, Choong‐Chin Liew, Michael J. Sole, Peter R. McLaughlin, Janet Rossant, S L Ang, Li T, Yunfeng Pan, Xiangyu Deng and Zijun Liao and has published in prestigious journals such as Circulation, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

O. Jin

9 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Jin China 5 218 75 71 60 56 11 328
Л. А. Грачева Russia 4 265 1.2× 91 1.2× 64 0.9× 48 0.8× 52 0.9× 11 372
Michael Stille‐Siegener Germany 11 268 1.2× 66 0.9× 26 0.4× 82 1.4× 65 1.2× 12 362
Günter Hufnagel Germany 8 302 1.4× 78 1.0× 17 0.2× 60 1.0× 108 1.9× 12 364
Gail M. Schauer United States 7 82 0.4× 145 1.9× 20 0.3× 16 0.3× 74 1.3× 10 350
Danielle Sartini United States 8 232 1.1× 48 0.6× 11 0.2× 241 4.0× 60 1.1× 9 358
Shigekazu Fujioka Japan 9 205 0.9× 45 0.6× 17 0.2× 27 0.5× 60 1.1× 20 260
S. Klaymé Lebanon 13 29 0.1× 33 0.4× 33 0.5× 98 1.6× 171 3.1× 15 332
Matthew Reed United Kingdom 11 330 1.5× 85 1.1× 8 0.1× 24 0.4× 19 0.3× 14 485
Murilo Delgobo Germany 10 65 0.3× 86 1.1× 8 0.1× 100 1.7× 39 0.7× 16 249
Diana Hernández-Flórez Spain 12 51 0.2× 32 0.4× 247 3.5× 95 1.6× 39 0.7× 35 422

Countries citing papers authored by O. Jin

Since Specialization
Citations

This map shows the geographic impact of O. Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Jin more than expected).

Fields of papers citing papers by O. Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Jin. The network helps show where O. Jin may publish in the future.

Co-authorship network of co-authors of O. Jin

This figure shows the co-authorship network connecting the top 25 collaborators of O. Jin. A scholar is included among the top collaborators of O. Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Jin. O. Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fang, Lin, Ze‐Xiao Lin, Zetao Liao, O. Jin, & Jun Gu. (2020). THU0385 SAFETY OF TOFACITINIB THERAPY IN HBSAG CARRIERS WITH ANKYLOSING SPONDYLITIS: A PROSPECTIVE STUDY. Annals of the Rheumatic Diseases. 79. 427–427. 1 indexed citations
2.
Jin, O., Xinling Zhang, Dongjun Lin, et al.. (2016). THU0274 Upregulation of NOD2 Involved in The Inflammatory Response by Activation of MAPK Signaling Pathway in Lupus Nephritis. Annals of the Rheumatic Diseases. 75. 286–286. 2 indexed citations
3.
Liao, Zhiwei, et al.. (2015). FRI0121 Safety of Adalimumab Therapy in HBSAG Carriers with Rheumatoid Arthritis: A Prospective Study. Annals of the Rheumatic Diseases. 74. 464–464.
4.
Xiao, Wei, et al.. (2015). Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma.. PubMed. 36(2). 146–9. 8 indexed citations
5.
Liao, Zetao, et al.. (2015). THU0242 Safety of Adalimumab Therapy in HBSAG Carriers with Ankylosing Spondylitis: A Prospective Study. Annals of the Rheumatic Diseases. 74. 285–285.
7.
Lau, Chak Sing, Mandana Nikpour, Sandra Navarra, et al.. (2013). THU0298 Consensus Definition of a Low Disease Activity State in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 72. A267–A267. 1 indexed citations
9.
Jin, O., et al.. (2006). Plasmacytoid-dendritic cell induced T cell proliferation and activation: a potential role in the pathogenesis of rheumatoid arthritis. 1 indexed citations
10.
Jin, O., et al.. (2001). Otx2 and HNF3beta genetically interact in anterior patterning.. PubMed. 45(1). 357–65. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026